Arrow Mark Colorado Holdings LLC Adaptive Biotechnologies Corp Transaction History

Arrow Mark Colorado Holdings LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $251,046 - $486,799	-10,062 Reduced 8.8%	104,224 $5.04 Million
Q1 2020 May 15, 2020	SELL	$16.96 - $34.16 $39,465 - $79,490	-2,327 Reduced 2.0%	114,286 $3.18 Million
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $598,428 - $799,204	-24,366 Reduced 17.28%	116,613 $3.49 Million
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $273,426 - $482,713	-9,021 Reduced 6.01%	140,979 $4.36 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $6.05 Million - $7.25 Million	150,000 New	150,000 $7.25 Million

225

146M

19.6K

27.2K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.18B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.